Paclitaxel in advanced urothelial carcinoma: Its role in patients with renal insufficiency and as salvage therapy

Journal of Urology

Volumn 156, Issue 5, 1996, Pages 1606-1608

  Dreicer, Robert ^a   Gustin, David M ^a   See, William A ^a   Williams, Richard D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

bladder neoplasms; drug therapy; kidney failure; neoplasm metastasis

Indexed keywords

CARBOPLATIN; CIMETIDINE; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; GALLIUM NITRATE; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; PIRITREXIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOPOTECAN; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER NECK STENOSIS; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYSTOSCOPY; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; INTRAVENOUS UROGRAPHY; KIDNEY FAILURE; LEUKOPENIA; MALE; METASTASIS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URETER OBSTRUCTION; UROGENITAL TRACT CANCER;

EID: 0029853721     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65459-4     Document Type: Article

References (14)

1. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Geller, N., Herr. H. W., Morse, M. J., Soeani, P. C., Vauehan, E. D., Bander, N., Weiselberg, L., Rosado, K., Smart, T. and Lin, S.: Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium: efficacy and patterns of response and relapse. Cancer, 64: 2448, 1989.
2. Loehrer, P. J., Einhorn, L. H., Elson, P. J., Crawford, E. D., Kuebler, P., Tannock, I., Raghavan, D., Stuart-Harris, R., Sarosdy, M. F., Lowe, B. A., Blumenstein, B. and Trump, D.: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J. Clin. Oncol., 10: 1066, 1992.
3. Witte, R., Loehrer, P., Dreicer, R., Williams, S. and Elson, P.: Ifosfamide in advanced urothelial carcinoma: an ECOG trial. Proc. Amer. Soc. Clin. Oncol., 12: 230, abstract 707, 1993.
4. Seidman, A. D., Scher, H. I., Heinemann, M. H., Bajorin, D. F., Sternberg, C. N., Dershaw, D. D., Silverberg, M. and Bosl, G. J.: Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors. Cancer, 68: 2561, 1991.
5. Roth, B. J., Dreicer, R., Einhorn, L. H., Neuberg, D., Johnson, D. H., Smith, J. L., Hudes, G. R., Schultz, S. M. and Loehrer, P. J.: Significant activity of paclitaxel in advanced transitional cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group (E1892). J. Clin. Oncol., 12: 2264, 1994.
6. Allen, F. J. and Steenkamp, J. W.: Intravenous urography in patients with transitional cell carcinoma of the bladder. The incidence and implications of ureteral obstruction. South. African J. Surg., 30: 28, 1992.
7. Leibovitch, I., Ben-Chaim, J., Ramon, J., Madjar, I., Enbelberg, I. S. and Goldwasser, B.: The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder. J. Surg. Oncol., 52: 31, 1993.
8. Rowinsky, E. K., Cazenave, L. A. and Donehower, R. C.: Taxol: a novel investigational antimicrotubule agent. J. Natl. Cancer Inst., 82: 1247, 1990.
9. Roth, B. J. and Bajorin, D. F.: Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world. J. Urol., 153: 894, 1995.
10. Pollera, C. F., Ceribelli, A., Crecco, M. and Calabresi, F.: Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study. Ann. Oncol., 5: 182, 1994.
11. de Wit, R., Kaye, S. B., Roberts, J. T., Stoter, G., Scott, J. and Verweij, J.: Oral piritexim, an effective treatment for metastatic urothelial cancer. Brit. J. Cancer, 67: 388, 1993.
12. Einhorn, L. H., Roth, B. J., Ansari, R., Dreicer, R., Gonin, R. and Loehrer, P. J.: Phase II trial of vinblastine, ifosfamide and gallium combination chemotherapy in metastatic urothelial carcinoma. J. Clin. Oncol., 12: 2271, 1994.
13. Bookman, M. A., McGuire, W. P., Kilpatrick, D., Keenan, E., Johnson, S., O'Dwyer, P., Rowinsky, E. and Ozols, R. F.: Phase-I gynecologic oncology group study of 3-H and 24-H paclitaxel with carboplatin as initial therapy for advanced epithelial ovarian cancer. Proc. Amer. Soc. Clin. Oncol., 14: 271, abstract 755, 1995.
14. Tan, V., Herrera, C., Einzig, A. I. and Wiernik, P. H.: Taxol is active as a 3 hour or 24 hour infusion in non-small cell lung cancer. Proc. Amer. Soc. Clin. Oncol., 14: 366, abstract 1122, 1995.